1. Home
  2. Advisory Committees
  3. Committees and Meeting Materials
  4. Human Drug Advisory Committees
  5. Pharmacy Compounding Advisory Committee
  6. Pharmacy Compounding Advisory Committee Roster
  1. Pharmacy Compounding Advisory Committee

Pharmacy Compounding Advisory Committee Roster

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration’s (FDA’s) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees. More info  

Current Number of Vacancies = 6
Note, one or more vacancies may be in the nomination process or a final appointment may have been made.
 
The names listed below are advisory committee members who have active appointments required to participate in committee meetings, including an unexpired appointment as a Special Government Employee where applicable.  

Chairperson
Vacant

Designated Federal Officer (DFO) 
Takyiah Stevenson, PharmD
Division of Advisory Committee and Consultant Management
Office of Executive Programs
Center for Drug Evaluation and Research
Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, Maryland 20993-0002
Phone: (301) 796-9001
Fax: (301) 847-8533
E-mail: PCAC@fda.hhs.gov

Timothy D. Fensky, RPh, DPh FACA 
Expertise: National Association of Boards of Pharmacy Representative
Term: 10/1/2018 – 9/30/2026
President/Principal Consultant
Pharmacy Insights
58 Alan Road
Marlborough, Massachusetts 01752

Elizabeth Rebello, RPh, MD, FASA, CPPS, CMQ
Expertise: Anesthesiology
Term: 10/1/2018– 9/30/2026
Professor
Department of Anesthesiology and Perioperative Medicine
University of Texas MD Anderson Cancer Center
1400 Holcombe Boulevard
Houston, Texas 77030

Brian Serumaga, PhD
Expertise: United States Pharmacopeia Representative
Term: 4/23/2022 – 9/30/2026
Director, Personalized Medicines
United States Pharmacopeial Convention
12601 Twinbrook Parkway
Rockville, Maryland 20852

**Donnette D. Staas, PhD
Expertise: Industry Representative
Term: 2/8/2024 to 10/31/2027
Vice President, Regulatory Strategy
Jazz Pharmaceuticals
2005 Market Street, Suite 2100
Philadelphia, Pennsylvania 19103

* Consumer Representative (vacant)
** Industry Representative (non-voting)

Updated: December 1, 2025

Back to Top